This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This AKR7A3 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 33-64 amino acids from the human region of human AKR7A3.
AKR7A3
Reactivity: Human
WB, EIA
Host: Mouse
Monoclonal
AT2E11
unconjugated
Application Notes
For WB starting dilution is: 1:2000
Restrictions
For Research Use only
Format
Liquid
Concentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
AKR7A3
(Aldo-Keto Reductase Family 7, Member A3 (Aflatoxin Aldehyde Reductase) (AKR7A3))
AFAR2 antibody, fd56g11 antibody, wu:fd56g11 antibody, zgc:92502 antibody, AKR7A2 antibody, Afar antibody, Akr7a1 antibody, aldo-keto reductase family 7 member A3 antibody, aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) antibody, aflatoxin B1 aldehyde reductase member 3 antibody, AKR7A3 antibody, akr7a3 antibody, LOC788425 antibody, Akr7a3 antibody
Background
Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen.